Company Information

Company Orexo AB
Pharmaceuticals & Biotechnology
Publicly Listed
Global Compact Status:
Participant Since
21 April 2017
Letter of Commitment
Next Communication on Progress (COP) due on:
31 July 2024

Financial Information

Twitter Feed from Orexo AB

Communication On Progress

Published On Title Level/Status
22-Dec-2023 2023 Communication on Progress Submitted
05-Apr-2022 Communication on Progress Orexo AB 2021 Active
30-Mar-2021 Communication on Progress Orexo AB Active
30-Mar-2020 Communication on Progress Active
20-Mar-2020 Reporting Cycle Adjustment Not applicable
25-Mar-2019 Sustainability Report 2018 (part of annual report) Active
27-Mar-2018 Orexo AB - Communication on Progress 2017 Active

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.